| Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections KE Remy, M Mazer, DA Striker, AH Ellebedy, AH Walton, J Unsinger, ... JCI insight 5 (17), 2020 | 334 | 2020 |
| Germinal centre-driven maturation of B cell response to mRNA vaccination W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz, T Lei, Z Liu, ... Nature 604 (7904), 141-145, 2022 | 268 | 2022 |
| SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 257 | 2022 |
| Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm PA Mudd, JC Crawford, JS Turner, A Souquette, D Reynolds, D Bender, ... Science advances 6 (50), eabe3024, 2020 | 238 | 2020 |
| Broadly protective human antibodies that target the active site of influenza virus neuraminidase D Stadlbauer, X Zhu, M McMahon, JS Turner, TJ Wohlbold, AJ Schmitz, ... Science 366 (6464), 499-504, 2019 | 224 | 2019 |
| Vaccine-induced CD8+ T cells control AIDS virus replication PA Mudd, MA Martins, AJ Ericsen, DC Tully, KA Power, AT Bean, ... Nature 491 (7422), 129-133, 2012 | 205 | 2012 |
| Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ... Science immunology 6 (59), eabh2259, 2021 | 204 | 2021 |
| Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19 S Dhindsa, N Zhang, MJ McPhaul, Z Wu, AK Ghoshal, EC Erlich, K Mani, ... JAMA network open 4 (5), e2111398-e2111398, 2021 | 192 | 2021 |
| Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19 D Scozzi, M Cano, L Ma, D Zhou, JH Zhu, JA O’Halloran, C Goss, ... JCI insight 6 (4), 2021 | 181 | 2021 |
| CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14 BK Patterson, H Seethamraju, K Dhody, MJ Corley, K Kazempour, ... International Journal of Infectious Diseases 103, 25-32, 2021 | 137 | 2021 |
| Diagnosing COVID‐19 in the emergency department: a scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases CR Carpenter, PA Mudd, CP West, E Wilber, ST Wilber Academic Emergency Medicine 27 (8), 653-670, 2020 | 133 | 2020 |
| Regulatory T cells and systemic lupus erythematosus PA Mudd, BN Teague, AD Farris Scandinavian journal of immunology 64 (3), 211-218, 2006 | 118 | 2006 |
| Cutting edge: Transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus BN Teague, Y Pan, PA Mudd, B Nakken, Q Zhang, P Szodoray, ... The Journal of Immunology 178 (12), 7511-7515, 2007 | 112 | 2007 |
| Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity M Sindelar, E Stancliffe, M Schwaiger-Haber, DS Anbukumar, ... Cell Reports Medicine 2 (8), 2021 | 107 | 2021 |
| Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19 MJ Corley, APS Pang, K Dody, PA Mudd, BK Patterson, H Seethamraju, ... Journal of leukocyte biology 110 (1), 21-26, 2021 | 106 | 2021 |
| Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in … MC Bonaldo, MA Martins, R Rudersdorf, PA Mudd, JB Sacha, ... Journal of virology 84 (7), 3699-3706, 2010 | 62 | 2010 |
| Human antibodies targeting influenza B virus neuraminidase active site are broadly protective A Madsen, YN Dai, M McMahon, AJ Schmitz, JS Turner, J Tan, T Lei, ... Immunity 53 (4), 852-863. e7, 2020 | 60 | 2020 |
| Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID M Plassmeyer, O Alpan, MJ Corley, TA Premeaux, K Lillard, P Coatney, ... Allergy 77 (1), 118-129, 2022 | 54 | 2022 |
| Escape from CD8+ T cell responses in Mamu-B* 00801+ macaques differentiates progressors from elite controllers PA Mudd, AJ Ericsen, BJ Burwitz, NA Wilson, DH O’Connor, AL Hughes, ... The Journal of Immunology 188 (7), 3364-3370, 2012 | 44 | 2012 |
| Targeted immunosuppression distinguishes COVID-19 from influenza in moderate and severe disease PA Mudd, JC Crawford, JS Turner, A Souquette, D Reynolds, D Bender, ... MedRxiv, 2020.05. 28.20115667, 2020 | 43 | 2020 |
